NCT04388371View on ClinicalTrials.gov

Glutamine PET Imaging in LAM

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

August 10, 2021

Conditions
Lymphangioleiomyomatosis (LAM)
Interventions
DRUG

Glutamine

Glutamine will be administered by IV injection prior to PET imaging.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

The LAM Foundation

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT04388371 - Glutamine PET Imaging in LAM | Biotech Hunter | Biotech Hunter